RPB researchers are working to understand and prevent macular degeneration, to halt its progression, and to develop optical devices to offset vision loss.
RPB and AUPO announce 2018 recipient of David F. Weeks Award for outstanding AMD research.
RPB-supported researchers at the University of Southern California Roski Eye Institute conducted the human trial.
RPB-supported researchers made a critical discovery about the gene mutation that causes many retinal degenerative diseases, opening the door for a new line of research into potential treatments.
The model will allow researchers to better assess treatments for this hard-to-study cause of blindness.
The findings may have significant therapeutic implications for AMD, the most common cause of elderly blindness in the developed world
|General Info||Research Scientists & Grantees||Eye Care Specialists||Donors & Partners|